[go: up one dir, main page]

Neuroectodermal Tumors, Primitive

"Neuroectodermal Tumors, Primitive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)


expand / collapse Publications
This graph shows the total number of publications written about "Neuroectodermal Tumors, Primitive" by people in this website by year, and whether "Neuroectodermal Tumors, Primitive" was a major or minor topic of these publications.
Below are the most recent publications written about "Neuroectodermal Tumors, Primitive" by people in Profiles.
  1. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Br J Cancer. 2024 Apr; 130(7):1096-1108.
    View in: PubMed
  2. Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium. Cancer Causes Control. 2023 Nov; 34(11):1005-1015.
    View in: PubMed
  3. Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis. Eur J Cancer. 2023 03; 182:43-52.
    View in: PubMed
  4. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol. 2023 01; 145(1):49-69.
    View in: PubMed
  5. Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA. Ophthalmic Genet. 2022 12; 43(6):855-861.
    View in: PubMed
  6. A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161. Invest New Drugs. 2022 12; 40(6):1306-1314.
    View in: PubMed
  7. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol. 2022 10; 144(4):733-746.
    View in: PubMed
  8. Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology. Pathol Int. 2022 Aug; 72(8):402-410.
    View in: PubMed
  9. Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance). Endocr Relat Cancer. 2022 05 09; 29(6):335-344.
    View in: PubMed
  10. Generalized methodology for radiomic feature selection and modeling in predicting clinical outcomes. Phys Med Biol. 2021 10 22; 66(21).
    View in: PubMed